BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9334541)

  • 21. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation.
    Riccio CA; Waldrop JJ; Reynolds CR; Lowe P
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):326-35. PubMed ID: 11514638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychopharmacological effects of methylphenidate].
    Ikeda K; Takamatsu Y; Hagino Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does methylphenidate constrict cognitive functioning?
    Solanto MV; Wender EH
    J Am Acad Child Adolesc Psychiatry; 1989 Nov; 28(6):897-902. PubMed ID: 2808260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medications do not necessarily normalize cognition in ADHD patients.
    Gualtieri CT; Johnson LG
    J Atten Disord; 2008 Jan; 11(4):459-69. PubMed ID: 17934180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder.
    Kobel M; Bechtel N; Weber P; Specht K; Klarhöfer M; Scheffler K; Opwis K; Penner IK
    Eur J Paediatr Neurol; 2009 Nov; 13(6):516-23. PubMed ID: 19056305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

  • 29. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation].
    Zetterström R
    Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717
    [No Abstract]   [Full Text] [Related]  

  • 30. Delta plots in the study of individual differences: new tools reveal response inhibition deficits in AD/Hd that are eliminated by methylphenidate treatment.
    Ridderinkhof KR; Scheres A; Oosterlaan J; Sergeant JA
    J Abnorm Psychol; 2005 May; 114(2):197-215. PubMed ID: 15869351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine motor skills and effects of methylphenidate in children with attention-deficit-hyperactivity disorder and developmental coordination disorder.
    Flapper BC; Houwen S; Schoemaker MM
    Dev Med Child Neurol; 2006 Mar; 48(3):165-9. PubMed ID: 16483390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
    Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
    J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
    Işeri E; Kiliç BG; Senol S; Karabacak NI
    Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate use and divorce.
    Schultz BK
    CMAJ; 2007 Sep; 177(7):751; author reply 751. PubMed ID: 17893352
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylphenidate.
    St Dennis C; Synoground G
    J Sch Nurs; 1996 Feb; 12(1):5-8, 10-1. PubMed ID: 8696016
    [No Abstract]   [Full Text] [Related]  

  • 39. The stimulants.
    Wilens TE; Biederman J
    Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zeroing in on attention deficit disorder.
    Health News; 1999 Feb; 5(2):7. PubMed ID: 9972114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.